Shopping Cart 0
Cart Subtotal
AED 0

Cardiopulmonary Exercise Testing Market Research Report by Product (Echocardiogram, Pulse Oximeters, Stress Blood Pressure Monitors, and Others), End-user (Hospital/Clinical Laboratories, Diagnostic Centers, Ambulatory Centers, and Others), and Region (APAC, Europe, North America, RoW)-Global Forecast to 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 16332

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 22938

Details

Cardiopulmonary Exercise Testing Market Research Report by Product (Echocardiogram, Pulse Oximeters, Stress Blood Pressure Monitors, and Others), End-user (Hospital/Clinical Laboratories, Diagnostic Centers, Ambulatory Centers, and Others), and Region (APAC, Europe, North America, RoW)-Global Forecast to 2023

Market analysis

Cardiopulmonary exercise testing is a viable method for diagnosing the heart condition and other cardiopulmonary traits. The test method incorporates checking the blood pressure, conducting the electrocardiography examination, and so on. Such tests are commonly practiced in developing nations attributable to the increasing health awareness among the individuals. This describes the exponential development of cardiopulmonary exercise testing in global regions like North America. The increasing prevalence of various cardiovascular diseases has led to an enhancement in the cardiopulmonary exercise testing in different global regions. The availability of the top-notch healthcare system has made the cardiopulmonary exercise testing highly competent in the global market. The global cardiopulmonary exercise testing market is projected to reach the valuation of USD 2248.21 Mn by growing at a CAGR of 5.75% during the forecast period (2018- 2023).

Market segmentation

The global cardiopulmonary exercise testing market is segmented on the basis of its product, end-user and regional demand. Based on its product, the global market is segmented into Single-Photon Emission Computed Tomography (SPECT), Cardiopulmonary Exercise Testing (CPET) Systems, Stress Blood Pressure Monitors, Pulse Oximeters, Echocardiogram, Others. On the basis of its end-users, the market is classified into ambulatory centers, hospitals and clinics, diagnostic centers and others.

Regional analysis

Geographically, the global cardiopulmonary exercise testing market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

COSMED srl, Masimo Corporation, GE Healthcare, Cardinal Health, Halma plc., Koninklijke Philips N.V., Hill-Rom Holdings, Inc., Schiller AG and Vyaire Medical, Inc, MGC Diagnostics Corporation, NIHON KOHDEN CORPORATION, among others are some of the major players in the global cardiopulmonary exercise testing market.

READ MORE

Table Of Content

Scope

Table of Contents:

 

1 Report Prologue

2 Introduction

2.1 Definition

2.2 Scope of the Study

2.3 Research Objective

2.4 Assumptions & Limitations

2.4.1 Assumptions

2.4.2 Limitations

2.4.3 Market Structure

3 Research Methodology

3.1 Primary Research Methodology

3.2 Secondary Research Methodology

3.3 Market Size Estimation

3.4 Forecast Model

4 Market Dynamics

4.1 Introduction

4.2 Drivers

4.2.1 Rising geriatric population

4.2.2 Rising cardiovascular diseases

4.2.3 Research and development

4.3 Restraints

4.3.1 High cost

4.3.2 Regulatory affairs

4.4 Opportunity

4.4.1 Entering developing markets

5 Market Factor Analysis

5.1 Porter's Five Forces Model

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Price Analysis

5.3 Investment Opportunity Analysis

5.4 Value Chain Analysis

5.4.1 Supporting Activity

5.4.2 Inbound Logistics

5.4.3 Operations

5.4.4 Marketing and Sales

5.4.5 Outbound Logistics

5.4.6 Customer Services

6 Global Cardiopulmonary Exercise Testing Market, by Product

6.1 Introduction

6.2 Cardiopulmonary Exercise Testing (CPET) Systems

6.3 Single-Photon Emission Computed Tomography (SPECT)

6.4 Echocardiogram

6.5 Pulse Oximeters

6.6 Stress Blood Pressure Monitors

7 Global Cardiopulmonary Exercise Testing Market, by End-User

7.1 Introduction

7.2 Hospitals and Clinics

7.3 Diagnostic Centers

7.4 Ambulatory Centers

7.5 Others

8 Global Cardiopulmonary Exercise Testing Market, by Region

8.1 Introduction

8.2 Americas

8.2.1 North America

8.2.1.1 U.S.

8.2.1.2 Canada

8.2.2 South America

8.3 Europe

8.3.1 Western Europe

8.3.1.1 Germany

8.3.1.2 France

8.3.1.3 U.K.

8.3.1.4 Italy

8.3.1.5 Spain

8.3.1.6 Rest of Western Europe

8.3.2 Eastern Europe

8.4 Asia-Pacific

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Australia

8.4.5 Republic of Korea

8.4.6 Rest of Asia-Pacific

8.5 Middle East and Africa

8.5.1 Middle East

8.5.2 Africa

9 Company Landscape

9.1 Company Share Analysis

10 Company Profiles

10.1 Cardinal Health

10.1.1 Company Overview

10.1.2 Financial Overview

10.1.3 Products Offering

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.1.6 Key Strategy

10.2 COSMED srl

10.2.1 Company Overview

10.2.2 Financial Overview

10.2.3 Products Offering

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.2.6 Key Strategy

10.3 GE Healthcare

10.3.1 Company Overview

10.3.2 Financial Overview (Healthcare Segment)

10.3.3 Products Offering

10.3.4 Key Developments

10.3.5 SWOT Analysis

10.3.6 Key Strategy

10.4 Halma plc.

10.4.1 Company Overview

10.4.2 Financial Overview

10.4.3 Products Offering

10.4.4 Key Developments

10.4.5 SWOT Analysis

10.4.6 Key Strategy

10.5 Hill-Rom Holdings, Inc.

10.5.1 Company Overview

10.5.2 Financial Overview

10.5.3 Products Offering

10.5.4 Key Developments

10.5.5 SWOT Analysis

10.5.6 Key Strategy

10.6 Koninklijke Philips N.V.

10.6.1 Company Overview

10.6.2 Financial Overview

10.6.3 Products Offering

10.6.4 Key Developments

10.6.5 SWOT Analysis

10.6.6 Key Strategy

10.7 MGC Diagnostics Corporation

10.7.1 Company Overview

10.7.2 Financial Overview

10.7.3 Products Offering

10.7.4 Key Developments

10.7.5 SWOT Analysis

10.7.6 Key Strategy

10.8 NIHON KOHDEN CORPORATION

10.8.1 Company Overview

10.8.2 Financial Overview

10.8.3 Products Offering

10.8.4 Key Developments

10.8.5 SWOT Analysis

10.8.6 Key Strategy

10.9 Schiller AG

10.9.1 Company Overview

10.9.2 Financial Overview

10.9.3 Products Offering

10.9.4 Key Developments

10.9.5 SWOT Analysis

10.9.6 Key Strategy

10.1 Masimo Corporation

10.10.1 Company Overview

10.10.2 Financial Overview

10.10.3 Products Offering

10.10.4 Key Developments

10.10.5 SWOT Analysis

10.10.6 Key Strategy

10.11 Vyaire Medical, Inc.

10.11.1 Company Overview

10.11.2 Financial Overview

10.11.3 Products Offering

10.11.4 Key Developments

10.11.5 SWOT Analysis

10.11.6 Key Strategy

11 Appendix

11.1 Discussion Blue Print

11.2 References


List Of Figure

List of Figures:

 

FIGURE 1 TOP-DOWN & BOTTOM-UP APPROACHES

FIGURE 2 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET

FIGURE 3 PORTER'S FIVE FORCES MODEL

FIGURE 4 VALUE CHAIN: CARDIOPULMONARY EXERCISE TESTING MARKET

FIGURE 5 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2017 & 2023 (USD MILLION)

FIGURE 6 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2017 & 2023 (USD MILLION)

FIGURE 7 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2017 & 2023 (USD MILLION)

FIGURE 8 AMERICAS CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2017 (%)

FIGURE 9 NORTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2017 (%)

FIGURE 10 EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2017 (%)

FIGURE 11 WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2017 (%)

FIGURE 12 ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2017(%)

FIGURE 13 MIDDLE EAST & AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2017 (%)

FIGURE 14 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET COMPANY SHARE ANALYSIS, 2017 (%)


List Of Table

List of Tables:

 

TABLE 1 PRIMARY INTERVIEWS

TABLE 2 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 3 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR CARDIOPULMONARY EXERCISE TESTING (CPET) SYSTEMS, BY REGION, 2015-2023 (USD MILLION)

TABLE 4 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT), BY REGION, 2015-2023 (USD MILLION)

TABLE 5 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR ECHOCARDIOGRAM, BY REGION, 2015-2023 (USD MILLION)

TABLE 6 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR PULSE OXIMETERS, BY REGION, 2015-2023 (USD MILLION)

TABLE 7 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR STRESS BLOOD PRESSURE MONITORS, BY REGION, 2015-2023 (USD MILLION)

TABLE 8 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 9 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2015-2023 (USD MILLION)

TABLE 10 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2015-2023 (USD MILLION)

TABLE 11 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR AMBULATORY CENTERS, BY REGION, 2015-2023 (USD MILLION)

TABLE 12 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 13 AMERICAS CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 14 AMERICAS CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 15 AMERICAS CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 16 NORTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2015-2023 (USD MILLION)

TABLE 17 NORTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 18 NORTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 19 U.S. CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 20 U.S. CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 21 CANADA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 22 CANADA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 23 SOUTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 24 SOUTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 25 EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 26 EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 27 EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 28 WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2015-2023 (USD MILLION)

TABLE 29 WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 30 WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 31 GERMANY CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 32 GERMANY CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 33 FRANCE CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 34 FRANCE CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 35 U.K. CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 36 U.K. CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 37 ITALY CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 38 ITALY CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 39 SPAIN CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 40 SPAIN CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 41 REST OF WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 42 REST OF WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 43 EASTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 44 EASTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 45 ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2015-2023 (USD MILLION)

TABLE 46 ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 47 ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 48 JAPAN CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 49 JAPAN CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 50 CHINA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 51 CHINA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 52 INDIA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 53 INDIA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 54 AUSTRALIA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 55 AUSTRALIA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 56 REPUBLIC OF KOREA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 57 REPUBLIC OF KOREA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 58 REST OF ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 59 REST OF ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 60 MIDDLE EAST & AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 61 MIDDLE EAST & AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 62 MIDDLE EAST & AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 63 MIDDLE EAST CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 64 MIDDLE EAST CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 65 AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 66 AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

Licence Rights

"Single User License: OnIine PDF View Only
Enterprise-user License : Print & download option is available."

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

COSMED srl, Masimo Corporation, GE Healthcare, Cardinal Health, Halma plc., Koninklijke Philips N.V., Hill-Rom Holdings, Inc., Schiller AG and Vyaire Medical, Inc, MGC Diagnostics Corporation, NIHON KOHDEN CORPORATION

Company Profile

Company Profile Title

Cardiopulmonary Exercise Testing Market Research Report by Product (Echocardiogram, Pulse Oximeters, Stress Blood Pressure Monitors, and Others), End-user (Hospital/Clinical Laboratories, Diagnostic Centers, Ambulatory Centers, and Others), and Region (APAC, Europe, North America, RoW)-Global Forecast to 2023

Market analysis

Cardiopulmonary exercise testing is a viable method for diagnosing the heart condition and other cardiopulmonary traits. The test method incorporates checking the blood pressure, conducting the electrocardiography examination, and so on. Such tests are commonly practiced in developing nations attributable to the increasing health awareness among the individuals. This describes the exponential development of cardiopulmonary exercise testing in global regions like North America. The increasing prevalence of various cardiovascular diseases has led to an enhancement in the cardiopulmonary exercise testing in different global regions. The availability of the top-notch healthcare system has made the cardiopulmonary exercise testing highly competent in the global market. The global cardiopulmonary exercise testing market is projected to reach the valuation of USD 2248.21 Mn by growing at a CAGR of 5.75% during the forecast period (2018- 2023).

Market segmentation

The global cardiopulmonary exercise testing market is segmented on the basis of its product, end-user and regional demand. Based on its product, the global market is segmented into Single-Photon Emission Computed Tomography (SPECT), Cardiopulmonary Exercise Testing (CPET) Systems, Stress Blood Pressure Monitors, Pulse Oximeters, Echocardiogram, Others. On the basis of its end-users, the market is classified into ambulatory centers, hospitals and clinics, diagnostic centers and others.

Regional analysis

Geographically, the global cardiopulmonary exercise testing market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

COSMED srl, Masimo Corporation, GE Healthcare, Cardinal Health, Halma plc., Koninklijke Philips N.V., Hill-Rom Holdings, Inc., Schiller AG and Vyaire Medical, Inc, MGC Diagnostics Corporation, NIHON KOHDEN CORPORATION, among others are some of the major players in the global cardiopulmonary exercise testing market.

READ MORE

Scope

Table of Contents:

 

1 Report Prologue

2 Introduction

2.1 Definition

2.2 Scope of the Study

2.3 Research Objective

2.4 Assumptions & Limitations

2.4.1 Assumptions

2.4.2 Limitations

2.4.3 Market Structure

3 Research Methodology

3.1 Primary Research Methodology

3.2 Secondary Research Methodology

3.3 Market Size Estimation

3.4 Forecast Model

4 Market Dynamics

4.1 Introduction

4.2 Drivers

4.2.1 Rising geriatric population

4.2.2 Rising cardiovascular diseases

4.2.3 Research and development

4.3 Restraints

4.3.1 High cost

4.3.2 Regulatory affairs

4.4 Opportunity

4.4.1 Entering developing markets

5 Market Factor Analysis

5.1 Porter's Five Forces Model

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Price Analysis

5.3 Investment Opportunity Analysis

5.4 Value Chain Analysis

5.4.1 Supporting Activity

5.4.2 Inbound Logistics

5.4.3 Operations

5.4.4 Marketing and Sales

5.4.5 Outbound Logistics

5.4.6 Customer Services

6 Global Cardiopulmonary Exercise Testing Market, by Product

6.1 Introduction

6.2 Cardiopulmonary Exercise Testing (CPET) Systems

6.3 Single-Photon Emission Computed Tomography (SPECT)

6.4 Echocardiogram

6.5 Pulse Oximeters

6.6 Stress Blood Pressure Monitors

7 Global Cardiopulmonary Exercise Testing Market, by End-User

7.1 Introduction

7.2 Hospitals and Clinics

7.3 Diagnostic Centers

7.4 Ambulatory Centers

7.5 Others

8 Global Cardiopulmonary Exercise Testing Market, by Region

8.1 Introduction

8.2 Americas

8.2.1 North America

8.2.1.1 U.S.

8.2.1.2 Canada

8.2.2 South America

8.3 Europe

8.3.1 Western Europe

8.3.1.1 Germany

8.3.1.2 France

8.3.1.3 U.K.

8.3.1.4 Italy

8.3.1.5 Spain

8.3.1.6 Rest of Western Europe

8.3.2 Eastern Europe

8.4 Asia-Pacific

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Australia

8.4.5 Republic of Korea

8.4.6 Rest of Asia-Pacific

8.5 Middle East and Africa

8.5.1 Middle East

8.5.2 Africa

9 Company Landscape

9.1 Company Share Analysis

10 Company Profiles

10.1 Cardinal Health

10.1.1 Company Overview

10.1.2 Financial Overview

10.1.3 Products Offering

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.1.6 Key Strategy

10.2 COSMED srl

10.2.1 Company Overview

10.2.2 Financial Overview

10.2.3 Products Offering

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.2.6 Key Strategy

10.3 GE Healthcare

10.3.1 Company Overview

10.3.2 Financial Overview (Healthcare Segment)

10.3.3 Products Offering

10.3.4 Key Developments

10.3.5 SWOT Analysis

10.3.6 Key Strategy

10.4 Halma plc.

10.4.1 Company Overview

10.4.2 Financial Overview

10.4.3 Products Offering

10.4.4 Key Developments

10.4.5 SWOT Analysis

10.4.6 Key Strategy

10.5 Hill-Rom Holdings, Inc.

10.5.1 Company Overview

10.5.2 Financial Overview

10.5.3 Products Offering

10.5.4 Key Developments

10.5.5 SWOT Analysis

10.5.6 Key Strategy

10.6 Koninklijke Philips N.V.

10.6.1 Company Overview

10.6.2 Financial Overview

10.6.3 Products Offering

10.6.4 Key Developments

10.6.5 SWOT Analysis

10.6.6 Key Strategy

10.7 MGC Diagnostics Corporation

10.7.1 Company Overview

10.7.2 Financial Overview

10.7.3 Products Offering

10.7.4 Key Developments

10.7.5 SWOT Analysis

10.7.6 Key Strategy

10.8 NIHON KOHDEN CORPORATION

10.8.1 Company Overview

10.8.2 Financial Overview

10.8.3 Products Offering

10.8.4 Key Developments

10.8.5 SWOT Analysis

10.8.6 Key Strategy

10.9 Schiller AG

10.9.1 Company Overview

10.9.2 Financial Overview

10.9.3 Products Offering

10.9.4 Key Developments

10.9.5 SWOT Analysis

10.9.6 Key Strategy

10.1 Masimo Corporation

10.10.1 Company Overview

10.10.2 Financial Overview

10.10.3 Products Offering

10.10.4 Key Developments

10.10.5 SWOT Analysis

10.10.6 Key Strategy

10.11 Vyaire Medical, Inc.

10.11.1 Company Overview

10.11.2 Financial Overview

10.11.3 Products Offering

10.11.4 Key Developments

10.11.5 SWOT Analysis

10.11.6 Key Strategy

11 Appendix

11.1 Discussion Blue Print

11.2 References


List Of Figure

List of Figures:

 

FIGURE 1 TOP-DOWN & BOTTOM-UP APPROACHES

FIGURE 2 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET

FIGURE 3 PORTER'S FIVE FORCES MODEL

FIGURE 4 VALUE CHAIN: CARDIOPULMONARY EXERCISE TESTING MARKET

FIGURE 5 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2017 & 2023 (USD MILLION)

FIGURE 6 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2017 & 2023 (USD MILLION)

FIGURE 7 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2017 & 2023 (USD MILLION)

FIGURE 8 AMERICAS CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2017 (%)

FIGURE 9 NORTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2017 (%)

FIGURE 10 EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2017 (%)

FIGURE 11 WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2017 (%)

FIGURE 12 ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2017(%)

FIGURE 13 MIDDLE EAST & AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2017 (%)

FIGURE 14 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET COMPANY SHARE ANALYSIS, 2017 (%)


List Of Table

List of Tables:

 

TABLE 1 PRIMARY INTERVIEWS

TABLE 2 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 3 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR CARDIOPULMONARY EXERCISE TESTING (CPET) SYSTEMS, BY REGION, 2015-2023 (USD MILLION)

TABLE 4 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT), BY REGION, 2015-2023 (USD MILLION)

TABLE 5 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR ECHOCARDIOGRAM, BY REGION, 2015-2023 (USD MILLION)

TABLE 6 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR PULSE OXIMETERS, BY REGION, 2015-2023 (USD MILLION)

TABLE 7 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR STRESS BLOOD PRESSURE MONITORS, BY REGION, 2015-2023 (USD MILLION)

TABLE 8 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 9 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2015-2023 (USD MILLION)

TABLE 10 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2015-2023 (USD MILLION)

TABLE 11 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR AMBULATORY CENTERS, BY REGION, 2015-2023 (USD MILLION)

TABLE 12 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 13 AMERICAS CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 14 AMERICAS CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 15 AMERICAS CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 16 NORTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2015-2023 (USD MILLION)

TABLE 17 NORTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 18 NORTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 19 U.S. CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 20 U.S. CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 21 CANADA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 22 CANADA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 23 SOUTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 24 SOUTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 25 EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 26 EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 27 EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 28 WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2015-2023 (USD MILLION)

TABLE 29 WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 30 WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 31 GERMANY CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 32 GERMANY CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 33 FRANCE CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 34 FRANCE CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 35 U.K. CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 36 U.K. CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 37 ITALY CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 38 ITALY CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 39 SPAIN CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 40 SPAIN CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 41 REST OF WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 42 REST OF WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 43 EASTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 44 EASTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 45 ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2015-2023 (USD MILLION)

TABLE 46 ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 47 ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 48 JAPAN CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 49 JAPAN CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 50 CHINA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 51 CHINA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 52 INDIA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 53 INDIA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 54 AUSTRALIA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 55 AUSTRALIA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 56 REPUBLIC OF KOREA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 57 REPUBLIC OF KOREA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 58 REST OF ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 59 REST OF ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 60 MIDDLE EAST & AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 61 MIDDLE EAST & AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 62 MIDDLE EAST & AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 63 MIDDLE EAST CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 64 MIDDLE EAST CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 65 AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2015-2023 (USD MILLION)

TABLE 66 AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2015-2023 (USD MILLION)

"Single User License: OnIine PDF View Only
Enterprise-user License : Print & download option is available."

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

COSMED srl, Masimo Corporation, GE Healthcare, Cardinal Health, Halma plc., Koninklijke Philips N.V., Hill-Rom Holdings, Inc., Schiller AG and Vyaire Medical, Inc, MGC Diagnostics Corporation, NIHON KOHDEN CORPORATION